Design and clinical application of a risk prediction model for diabetic foot.

Xiaoping Yang, Shaohong Chen, Leiquan Ji, Qiaohui Chen, Chujia Lin
Author Information
  1. Xiaoping Yang: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College Shantou 515041, Guangdong, China.
  2. Shaohong Chen: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College Shantou 515041, Guangdong, China.
  3. Leiquan Ji: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College Shantou 515041, Guangdong, China.
  4. Qiaohui Chen: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College Shantou 515041, Guangdong, China.
  5. Chujia Lin: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College Shantou 515041, Guangdong, China.

Abstract

OBJECTIVE: To construct and evaluate a nomogram prediction model for the risk of diabetic foot in patients with type 2 diabetes based on their clinical data, and to assist clinical healthcare professionals in identifying high-risk factors and developing targeted intervention measures.
METHODS: We retrospectively collected clinical data from 478 hospitalized patients with type 2 diabetes at the First Affiliated Hospital of Shantou University Medical College from January 2019 to December 2021. The patients were divided into a diabetic foot group (n=312) and a non-diabetic foot group (n=166) based on whether they had diabetic foot. The baseline data of both groups were collected. Univariate and multivariate analyses as well as logistic regression analysis were conducted to explore the risk factors for diabetic foot. A nomogram prediction model was established using the package "rms" version 4.3. The model was internally validated using the area under the receiver operating characteristic curve (AUC). Additionally, the decision curve analysis (DCA) was performed to evaluate the performance of the nomogram model.
RESULTS: The results from the logistic regression analysis revealed that being male, smoking, duration of diabetes, glycated hemoglobin, hyperlipidemia, and atherosclerosis were influencing factors for diabetic foot (all P<0.05). The AUC of the model in predicting diabetic foot was 0.804, with a sensitivity of 75.3% and specificity of 74.4%. Harrell's C-index of the nomogram prediction model for diabetic foot was 0.804 (95% CI: 0.762-0.844), with a threshold value of >0.675. The DCA findings demonstrated that the nomogram model provided a net clinical benefit.
CONCLUSION: The nomogram prediction model constructed in this study showed good predictive performance and can provide a basis for clinical workers to prevent and intervene in diabetic foot, thereby improving the overall diagnosis and treatment.

Keywords

References

  1. Nutrients. 2021 Dec 30;14(1): [PMID: 35011044]
  2. BMC Endocr Disord. 2020 Mar 20;20(1):40 [PMID: 32192488]
  3. Medicina (Kaunas). 2022 Mar 16;58(3): [PMID: 35334607]
  4. Biomed Pharmacother. 2022 Jul;151:113134 [PMID: 35617802]
  5. Nat Rev Nephrol. 2020 Jul;16(7):377-390 [PMID: 32398868]
  6. Medicina (Kaunas). 2019 Aug 29;55(9): [PMID: 31470636]
  7. J Cardiovasc Surg (Torino). 2018 Oct;59(5):670-684 [PMID: 29808982]
  8. J Diabetes Sci Technol. 2020 Jan;14(1):3-7 [PMID: 30897962]
  9. Int Wound J. 2019 Feb;16(1):183-210 [PMID: 30393976]
  10. Redox Biol. 2019 Jan;20:247-260 [PMID: 30384259]
  11. Int J Mol Sci. 2022 Aug 09;23(16): [PMID: 36012115]
  12. Lipids Health Dis. 2020 Nov 7;19(1):234 [PMID: 33160371]
  13. Gut Microbes. 2022 Jan-Dec;14(1):2003176 [PMID: 34923903]
  14. Int J Mol Sci. 2022 Sep 06;23(18): [PMID: 36142181]
  15. Clin Chem Lab Med. 2022 Apr 27;60(7):961-974 [PMID: 35470641]
  16. Front Endocrinol (Lausanne). 2022 Dec 09;13:1079725 [PMID: 36568108]
  17. EBioMedicine. 2022 Aug;82:104154 [PMID: 35816897]
  18. Osteoporos Int. 2018 Dec;29(12):2585-2596 [PMID: 30066131]
  19. Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):251-256 [PMID: 30788010]
  20. Cancer Commun (Lond). 2020 Jul;40(7):301-312 [PMID: 32558385]
  21. Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S1-S7 [PMID: 31860923]
  22. J Diabetes Investig. 2021 May;12(5):790-802 [PMID: 32902171]
  23. Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F456-F462 [PMID: 31241989]
  24. BMC Gastroenterol. 2020 Oct 20;20(1):347 [PMID: 33081695]
  25. Adv Wound Care (New Rochelle). 2022 Dec;11(12):666-686 [PMID: 34376065]
  26. Int J Environ Res Public Health. 2022 Oct 14;19(20): [PMID: 36293800]
  27. J Tradit Chin Med. 2019 Feb;39(1):133-138 [PMID: 32186034]

Word Cloud

Created with Highcharts 10.0.0footmodeldiabeticnomogramclinicalpredictionriskpatientsdiabetesdatafactorsanalysis0evaluatetype2basedcollectedgrouplogisticregressionusingcurveAUCDCAperformance804applicationOBJECTIVE:constructassisthealthcareprofessionalsidentifyinghigh-riskdevelopingtargetedinterventionmeasuresMETHODS:retrospectively478hospitalizedFirstAffiliatedHospitalShantouUniversityMedicalCollegeJanuary2019December2021dividedn=312non-diabeticn=166whetherbaselinegroupsUnivariatemultivariateanalyseswellconductedexploreestablishedpackage"rms"version43internallyvalidatedareareceiveroperatingcharacteristicAdditionallydecisionperformedRESULTS:resultsrevealedmalesmokingdurationglycatedhemoglobinhyperlipidemiaatherosclerosisinfluencingP<005predictingsensitivity753%specificity744%Harrell'sC-index95%CI:762-0844thresholdvalue>0675findingsdemonstratedprovidednetbenefitCONCLUSION:constructedstudyshowedgoodpredictivecanprovidebasisworkerspreventintervenetherebyimprovingoveralldiagnosistreatmentDesignDiabetes

Similar Articles

Cited By